Latest Articles
Cervical cancer: Prevention through awareness, screening - Northside Hospital
Cervical cancer: Prevention through awareness, screening Northside Hospital
Published: April 1, 2025, 3:28 p.m.
NHS announces 'world leading' DIY smear tests plan to eradicate cervical cancer by 2040 - The Mirror
NHS announces 'world leading' DIY smear tests plan to eradicate cervical cancer by 2040 The Mirror
Published: March 28, 2025, 11:06 a.m.
Teenage girls urged to prioritise reproductive health to prevent Cervical Cancer - MSN
Teenage girls urged to prioritise reproductive health to prevent Cervical Cancer MSN
Published: March 15, 2025, 3:43 p.m.
Cervical cancer surge in India: Doctors advise women in 30s to start regular screening with pap smears and HP - Indiatimes.com
Cervical cancer surge in India: Doctors advise women in 30s to start regular screening with pap smears and HP Indiatimes.com
Published: Jan. 31, 2025, 11:07 a.m.
Cancelling cervical cancer - The New Indian Express
Cancelling cervical cancer The New Indian Express
Published: Jan. 29, 2025, 6:08 a.m.
Four early warning signs of cervical cancer that women often mistake for something else - Tyla
Four early warning signs of cervical cancer that women often mistake for something else Tyla
Published: Jan. 28, 2025, 12:44 p.m.
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan - springermedicine.com
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced …
Published: Dec. 28, 2024, 12:47 p.m.
Transforming cervical cancer protection with the BD Onclarity HPV Assay - Contemporary Obgyn
Transforming cervical cancer protection with the BD Onclarity HPV Assay Contemporary Obgyn
Published: Nov. 25, 2024, 6:54 p.m.
Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer - OncLive
Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer OncLive
Published: Oct. 24, 2024, 3:55 p.m.
Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More - OncLive
Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More OncLive
Published: Oct. 21, 2024, 5:04 p.m.
Link copied to clipboard!